Bafna Pharmaceuticals share news and announcements

NSE: BAFNAPHBSE: 532989Pharmaceuticals & BiotechnologySmall Cap

₹442.95₹9.00 (1.99%)BSE ₹449.85

Share price at the NSE close on 23 Oct 2026. Previous close ₹451.95.

52-week range of traded prices to 23 Oct 2026

₹94.77Low, 16 Mar 2026₹479.95High, 21 Oct 2026

Delivery only: shares bought must be paid for in full, with no selling on the same day.

Market cap: ₹1,048 Cr2,105th largest listed
P/E: 134.6
P/B: 10.9
Dividend yield: Nonein the last 12 months
ROE: 8.6%
ROCE: 4.0%
Debt to equity: 0.39
Volume, NSE: 1,422

Bafna Pharmaceuticals routine notices

72 filed, newest first. Page 1 of 2.

Oct 2026
- 12 Oct · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026 (opens in a new tab)
- 12 Oct · Routine
  Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended September 30, 2026 (opens in a new tab)
Sep 2026
- 26 Sep · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
- 26 Sep · Routine
  Intimation for Closure of Trading Window (opens in a new tab)
Aug 2026
- 21 Aug · Routine
  Copy of Newspaper Publication for the 31st Annual General Meeting of the Company published in 'Business Standard' and 'Makkal Kural' on August 20, 2026 (opens in a new tab)
- 14 Aug · Routine
  Copy of Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter ended June 30, 2026 as published in 'Business Standard' and 'Makkal Kural' on August 13, 2026 (opens in a new tab)
Jul 2026
- 9 Jul · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2026. (opens in a new tab)
Jun 2026
- 26 Jun · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
- 1 Jun · Routine
  Copy of Newspaper Publication for the Audited Financial Results of the Company for the Quarter & Year ended March 31, 2026 as published in "Financial Express" and "Makkal Kural" on May 31, 2026. (opens in a new tab)
Apr 2026
- 13 Apr · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31, 2026. (opens in a new tab)
Mar 2026
- 26 Mar · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
Feb 2026
- 14 Feb · Routine
  Copy of Newspaper Publication for the Unaudited Financial Results of the Company for the Quarter and Nine-Months ended December 31, 2025 as published in "Business Standard" and "Makkal Kural" on February 13, 2026 (opens in a new tab)
Jan 2026
- 9 Jan · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended December 31, 2025. (opens in a new tab)
Dec 2025
- 26 Dec · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
Nov 2025
- 14 Nov · Routine
  Copy of Newspaper Publication of the extract of the Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2025, as published in "Business Standard" and "Makkal Kural" on November 13, 2025. (opens in a new tab)
Oct 2025
- 10 Oct · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended September 30, 2025 (opens in a new tab)
Sep 2025
- 26 Sep · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
Aug 2025
- 28 Aug · Routine
  Copy of Newspaper Publication in connection with the 30th Annual General Meeting of the Company (opens in a new tab)
- 14 Aug · Routine
  Copy of Newspaper Publication of the Extract of the Unaudited Financial Results of the Company for the Quarter ended June 30, 2025 in "Business Standard" and "Makkal Kural" on August 14, 2025. (opens in a new tab)
Jul 2025
- 5 Jul · Routine
  Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended June 30, 2025 (opens in a new tab)
Jun 2025
- 26 Jun · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
May 2025
- 30 May · Routine
  Copy of Newspaper Publication in connection with Audited Financial Results of the Company for the Quarter and Year ended March 31, 2025 published in "Business Standard" and "Makkal Kural" on May 28, 2025 (opens in a new tab)
Apr 2025
- 8 Apr · Routine
  Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the Quarter ended March 31, 2025 (opens in a new tab)
Mar 2025
- 26 Mar · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
Feb 2025
- 11 Feb · Routine
  Copy of Newspaper Publication in connection with Unaudited Financial Results of the Company for the Quarter and Nine Months ended December 31, 2024 (opens in a new tab)
Jan 2025
- 9 Jan · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended December 31, 2024 (opens in a new tab)
Dec 2024
- 25 Dec · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
Nov 2024
- 16 Nov · Routine
  Copy of Newspaper Publication in connection with Unaudited Financial Results of the Company for the Quarter and Half Year ended September 30, 2024 (opens in a new tab)
Oct 2024
- 10 Oct · Routine
  Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for quarter ended September 30, 2024 (opens in a new tab)
Sep 2024
- 28 Sep · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
- 3 Sep · Routine
  Copy of Newspaper Publication in connection with 29th Annual General Meeting of the Company. (opens in a new tab)
Aug 2024
- 16 Aug · Routine
  Copy of Newspaper Publication for the Unaudited Financial Results for the Quarter ended June 30, 2024 published in "Business Standard" & "Makkal Kural" on August 16, 2024. (opens in a new tab)
Jul 2024
- 11 Jul · Routine
  Certificate under Regulation 74(5) SEBI (Depositories and Participants) Regulations, 2018 for quarter ended June 30, 2024. (opens in a new tab)
Jun 2024
- 25 Jun · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
May 2024
- 31 May · Routine
  Copy of Newspaper Publication for the Audited Financial Results for the Quarter & Year ended March 31, 2024 published in "Business Standard" & "Makkal Kural" on May 31, 2024. (opens in a new tab)
Apr 2024
- 15 Apr · Routine
  Certificate under Regulation 74(5) SEBI (Depositories and Participants) Regulations, 2018 (opens in a new tab)
Mar 2024
- 25 Mar · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
Feb 2024
- 14 Feb · Routine
  Copy of Newspaper Publication (opens in a new tab)
Jan 2024
- 11 Jan · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 (opens in a new tab)
Dec 2023
- 29 Dec · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
Nov 2023
- 10 Nov · Routine
  Copy of Newspaper Publication (opens in a new tab)
Oct 2023
- 9 Oct · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 (opens in a new tab)
Sep 2023
- 29 Sep · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
Aug 2023
- 31 Aug · Routine
  Copy of Newspaper Publication (opens in a new tab)
Jul 2023
- 13 Jul · Routine
  Certificate under SEBI (Depositories and Participants) Regulations, 2018 (opens in a new tab)
Jun 2023
- 28 Jun · Routine
  Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 (opens in a new tab)
May 2023
- 30 May · Routine
  Annual Secretarial Compliance Report for the financial year ended March 31, 2023. (opens in a new tab)
- 29 May · Routine
  We herewith submit the Newspaper publications published for Audited Standalone Financial Results of the Company for the 4th quarter and year ended March 31, 2023. (opens in a new tab)
Jul 2022
- 6 Jul · Routine
  Newspaper Advertisements pursuant to Regulation 30 read with Schedule III and Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of newspaper advertisement published on 06th July 2022 in Business Standard (English) and Makkal kural (Tamil) regarding notice of the 27th Annual General Meeting ( AGM) of the Company for the Financial Year 2021 2022, to be held on Thursday, 28th July 2022 at 11: 00 am through video conferencing. (opens in a new tab)
Jun 2022
- 28 Jun · Routine
  Closure of trading window from 1st day of July 2022 till the end of Forty-Eight (48) hours after the declaration of unaudited Financial Results of the Company for the quarter ending 30th June 2022 (opens in a new tab)

Bafna Pharmaceuticals routine notices

Oct 2026

Sep 2026

Aug 2026

Jul 2026

Jun 2026

Apr 2026

Mar 2026

Feb 2026

Jan 2026

Dec 2025

Nov 2025

Oct 2025

Sep 2025

Aug 2025

Jul 2025

Jun 2025

May 2025

Apr 2025

Mar 2025

Feb 2025

Jan 2025

Dec 2024

Nov 2024

Oct 2024

Sep 2024

Aug 2024

Jul 2024

Jun 2024

May 2024

Apr 2024

Mar 2024

Feb 2024

Jan 2024

Dec 2023

Nov 2023

Oct 2023

Sep 2023

Aug 2023

Jul 2023

Jun 2023

May 2023

Jul 2022

Jun 2022